Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Phase 2 Randomized, Double-blind, Placebo-controlled Study of the Anti-nerve Growth Factor (NGF) Antibody Tanezumab in Subjects with Moderate to Severe Pain Due to Schwannomatosis

              Author:Silverman, Danielle   Da, Jennifer   Merker, Vanessa   Ly, Ina   Muzikansky, Alona   Parsons, Michael   Wolters, Pamela   Xu, Lei   Brown, Mark   Haghpassand, Mehrdad   Jordan, Justin   Plotkin, Scott   

              Session Name:P6: Pain: Research Studies  

              Topic:Pain  

              Program Number:P6.001  

              Author Institution:Massachusetts General Hospital, Boston, MA  Massachusetts General Hospital , Boston, MA  National Cancer Institute, Bethesda, MD  Massachusetts General Hospital , Boston , MA  Pfizer Inc., Kalamazoo, MI  Pfizer Inc. , Groton , CT